Akane Ishihara Selected Research

Akane Ishihara Research Topics

16	Body Weight (Weight, Body) 12/2009 - 06/2002
14	Obesity 12/2009 - 06/2002
4	Hyperphagia (Overeating) 06/2006 - 06/2002
2	Fatty Liver 08/2008 - 01/2007
1	Pain (Aches) 06/2009
1	Insulin Resistance 07/2008
1	Diabetes Mellitus 09/2006
1	Morbid Obesity 02/2006
1	Non-alcoholic Fatty Liver Disease 02/2006
1	Cognitive Dysfunction 01/2006
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2006
1	Epilepsy (Aura) 01/2006
1	Hyperinsulinism (Hyperinsulinemia) 05/2003
1	Hypercholesterolemia 05/2003

5	Neuropeptide YIBA 08/2009 - 06/2002
3	Insulin (Novolin)FDA Link 06/2009 - 06/2006
2	melanin-concentrating hormone (melanin concentrating hormone)IBA 12/2009 - 08/2008
2	CholesterolIBA 06/2009 - 06/2006
2	LigandsIBA 06/2009 - 09/2006
2	LeptinIBA 06/2009 - 06/2006
2	Messenger RNA (mRNA)IBA 01/2007 - 11/2003
2	Histamine (Histamine Dihydrochloride)FDA Link 09/2006 - 01/2006
2	neuropeptide Y5 receptorIBA 05/2006 - 05/2003
1	neuropeptide Y-Y1 receptorIBA 08/2009
1	Pharmaceutical PreparationsIBA 07/2009
1	Opioid Receptors (Opioid Receptor)IBA 06/2009
1	NociceptinIBA 06/2009
1	Triglycerides (Triacylglycerol)IBA 08/2008
1	Methionine (L-Methionine)FDA Link 08/2008
1	Choline (Choline Chloride)IBA 08/2008
1	sibutramine (Meridia)FDA Link 07/2008
1	Spironolactone (Aldactone)FDA LinkGeneric 07/2008
1	Collagen Type I (Type I Collagen)IBA 01/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007
1	imetitIBA 09/2006
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 09/2006
1	thioperamideIBA 09/2006
1	RFamide peptideIBA 06/2006
1	Leptin ReceptorsIBA 05/2006
1	Tetracycline (Achromycin)FDA LinkGeneric 02/2006
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 07/2005
1	DNA (Deoxyribonucleic Acid)IBA 11/2003
1	Peptides (Polypeptides)IBA 03/2003
1	CorticosteroneIBA 06/2002

7	Intraventricular Infusions 06/2009 - 03/2003
5	Oral Administration 09/2009 - 06/2002
1	Subcutaneous Infusions 07/2009